Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWLanepitant is a neurokinin-1 (NK1) receptor antagonist (Ki = 0.15 nM).1 It inhibits Ac-[Arg6,Sar9,Met(O2)11]-substance P6-11-induced increases in tail biting and scratching in mice when administered at doses of 1, 5, or 10 mg/kg. Lanepitant (10 mg/kg) inhibits late-phase formalin-induced increases in paw licking in mice. It reduces corneal opacity and neovascularization and decreases leukocyte infiltration in a mouse model of alkali burn-induced corneal damage when topically applied at a concentration of 6.4 mg/ml six times per day.2
WARNING This product is not for human or veterinary use.
1. LY303870, a centrally active neurokinin-
2. NK1 receptor antagonists as a new treatment for corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 55(10), 6783-6794 (2014).